Medartis Forecast, price target & analysts
Medartis Target price 2024 - Analyst rating & recommendation
Medartis Classifications & Recommendation:
Medartis Price Target
| Target Price | CHF85.00 |
| Price | CHF56.60 |
| Potential |
50.18%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Medartis price target 2025.
The average Medartis target price is CHF85.00.
This is
50.18%
register free of charge
|
|
| A rating was issued by 1 analysts: 0 Analysts recommend Medartis to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medartis stock has an average upside potential 2025 of
50.18%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million CHF | 212.01 | 239.00 |
| 15.97% | 12.73% | |
| EBITDA Margin | 15.30% | 16.67% |
| 72.25% | 8.95% |
1 Analyst has issued a sales forecast Medartis 2024 . The average Medartis sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Medartis 2024 . The average Medartis EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | 3.37 |
Based on analysts' sales estimates for 2024, the Medartis stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
